Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|November 17, 2017
Comparing the efficacy of disease-modifying therapies in multiple sclerosisDimos D Mitsikostas, Douglas S GoodinCurrent Neurology and Neuroscience Reports|December 24, 2011
Nocebo in headaches: implications for clinical practice and trial designDimos D MitsikostasTherapeutic Advances in Neurological Disorders|May 20, 2020
Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trialsPanagiotis Gklinos, Dimos D MitsikostasCurrent Opinion in Neurology|February 28, 2017
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studiesDimos D Mitsikostas, Uwe ReuterPharmaceuticals (Basel, Switzerland)|April 3, 2021
The Role of Galcanezumab in Migraine Prevention: Existing Data and Future DirectionsPanagiotis Gklinos, Dimos D MitsikostasCNS & Neurological Disorders Drug Targets|August 19, 2007
The role of glutamate and its receptors in migraineMichail Vikelis, Dimos D MitsikostasCentral Nervous System Agents in Medicinal Chemistry|September 1, 2012
Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the futureDimos D Mitsikostas, Peer Tfelt-HansenNeurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultationDimos D Mitsikostas, Christina I DeligianniCurrent Opinion in Neurology|June 8, 2022
Therapies targeting CGRP signaling for medication overuse headacheIoannis-Alexios Koumprentziotis, Dimos D MitsikostasPageof 15